↓ Skip to main content

SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia—a phase II randomised control trial study protocol

Overview of attention for article published in Trials, July 2021
Altmetric Badge

Mentioned by

twitter
13 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
59 Mendeley